{"id":347132,"date":"2026-11-14T16:19:49","date_gmt":"2026-11-14T10:49:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/kimia-biosciences-q2-results-fy27-pat-2-crore\/"},"modified":"2026-11-14T16:19:49","modified_gmt":"2026-11-14T10:49:49","slug":"kimia-biosciences-q2-results-fy27-pat-2-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/kimia-biosciences-q2-results-fy27-pat-2-crore\/","title":{"rendered":"Kimia Biosciences Q2 Results FY27: PAT Jumps 134.31% to Rs 2.39 Cr, Revenue Rs 26.81 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Kimia Biosciences Q2 Results FY27 were declared on 13 November 2026 on a standalone basis. Revenue fell 21.15% YoY to Rs 26.81 Cr from Rs 34.00 Cr, while net profit rose 134.31% to Rs 2.39 Cr from Rs 1.02 Cr. These quarterly results show YoY growth in Operating Profit and net profit alongside lower revenue.<\/p>\n<\/div>\n

Kimia Biosciences Ltd<\/a> (KIMIABL) Q2 Results FY27 announced on 13 November 2026, covering the company’s financial performance for the July to September quarter. The company reported Standalone results with revenue of Rs 26.81 Cr and PAT of Rs 2.39 Cr. The results date of 13 November 2026 anchors every comparison below, and Kimia Biosciences Q2 Results FY27 show revenue lower but profit higher than a year earlier.<\/p>\n

This Kimia Biosciences Q2 Results analysis covers the financial highlights, the business factors disclosed with the numbers, the FY27 outlook and the risks to watch. Readers who track results on the Univest Screener will find this results analysis organised in that order, beginning with the Financial Highlights table that follows.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n